HC Wainwright Reaffirms Buy Rating for XOMA (NASDAQ:XOMA)
XOMA (NASDAQ:XOMA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a note issued to investors on Friday,Benzinga reports. They currently have a $104.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would suggest a potential upside of 411.56% from the company’s current […]
XOMA (NASDAQ:XOMA – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a note issued to investors on Friday,Benzinga reports. They currently have a $104.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective would suggest a potential upside of 411.56% from the company’s current […]
